Claudon M, Dietrich BI, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP, et al. Guidelines and good clinical practice recommendations for contrastenhanced ultrasound (CEUS) in the liver - update 2012. Ultraschall Med 2013; 34: 11-29.
Pisca glia F, Nolsøe C, Dietrich CF, Cosgrove DO, Gilja OH, Bachmann NM, et al. The EFSUMB guidelines and recommendations on the clinical practice of contrast-enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 2012; 33: 33-59.
Li X, Liang P, Yu J, Yu XL, Liu FY, Cheng ZG, et al. Role of contrast-enhanced ultrasound in evaluating the efficiency of ultrasound guided percutaneous microwave ablation in patients with renal cell carcinoma. Radiol Oncol 2013; 47: 398-404.
Darge K, Papadopoulou F, Ntoulia A, Bulas DI, Coley BD, Fordham LA, et al. Safety of contrast-enhanced ultrasound in children for non-cardiac applications. Pediatr Radiol 2013; 43: 1063-73.
Riccab ona M. Application of a second-generation US contrast agent in infants and children--a European questionnaire-based survey. Pediatr Radiol 2012; 42: 1471-80.
Piskun owicz M, Kosiak W, Batko T, Piankowski A, Połczyńska K, Adamkiewicz-Drożyńska E. Safety of intravenous application of second-generation ultrasound contrast agent in children: prospective analysis. Ultrasound Med Biol 2015; 41: 1095-9.
Piscaglia F, Bolondi L. The safety of SonoVue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 2006; 32: 1369-75.
Sellars ME, Deganello A, Sidhu PS. Paediatric contrast-enhanced ultrasound (CEUS): a technique that requires co-operation for rapid implementation into clinical practice. Ultraschall Med 2014; 35: 203-6.
Piskunowicz M, Kosiak W, Batko T. Intravenous application of secondgeneration ultrasound contrast agents in children: a review of the literature. Ultraschall Med 2012; 33: 135-40.
Darge K, N toulia K, Evangelou V, Papadopoulou F. A meta-analysis of the diagnostic performance of contrast enhanced voiding urosonography (ce-VUS). Pediatr Radiol 2012; 42 (Suppl): S259-60.
Oldenburg A, Hohmann J, Skrok J, Albrecht T. Imaging of pediatric splenic injury with contrast-enhanced ultrasonography. Pediatr Radiol 2004; 34: 351-4.
Valentino M, Serra C, Pavlica P, Labate AM, Lima M, Baroncini S, et al. Blunt abdominal trauma: diagnostic performance of contrast-enhanced ultrasound in children – initial experience. Radiology 2008; 246: 903-9.
Jacob J, D eganello A, Sellars ME, Hadzic N, Sidhu PS. Contrast enhanced ultrasound (CEUS) characterization of grey-scale sonographic indeterminate focal liver lesions in pediatric practice. Ultraschall Med 2013; 34: 529-40.
Schreiber-Dietrich D, Cui XW, Piscaglia F, Gilja OH, Dietrich CF. Contrast enhanced ultrasound in pediatric patients: a real challenge. Z Gastroenterol 2014; 52: 1178-84.
Schreyer A G, Menzel C, Friderich C, Poschenrieder F, Egger L, Dornia C, et al. Comparison of high-resolution ultrasound and MR-enterography in patients with inflammatory bowel disease. World J Gastroenterol 2011; 17: 1018-25.
Spalinger J, Patriquin H, Miron MC, Marx G, Herzog D, Dubois J, et al. Doppler US in patient with Crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology 2000; 217: 787-91.
Neye H, Voderholzer W, Rickes S, Weber J, Wermke W, Lochs H. Evaluation of criteria for the activity of Crohn’s disease by power Doppler sonography. Dig Dis 2004; 22: 67-72.
Sjekavica I, Barbarić-Babić V, Šunjara V, Kralik M, Senečić-Čala I, Dujšin M, et al. Resistance index in mural arteries of thickened bowel wall: predictive value for Crohn disease activity assessment in pediatric patients. Wien KlinWochenschr 2013; 125: 254-60.
Allgayer H, Braden B, Dietrich CF. Transabdominal ultrasound in inflammatory bowel disease. Conventional and recently developed techniques – update. Medical Ultrason 2011; 13: 302-13.
De Franco A, Marzo M, Felice C, Pugliese D, Veronica AD, Bonomo L, et al. Ileal Crohn’s disease: CEUS determination of activity. Abdom Imaging 2012; 37: 359-68.
Leen E, Averkiou M, Ar diti M, Burns P, Bokor D, Gauthier T, et al. Dynamic contrast enhanced ultrasound assessment of the vascular effects of novel therapeutics in early stage trials. Eur Radiol 2012; 22: 1442-50.
Schreyer AG, Finkenzel ler T, Gössmann H, Daneschnejad M, Müller-Wille R, Schacherer D, et al. Microcirculation and perfusion with contrast enhanced ultrasound (CEUS) in Crohn’s disease: first results with linear contrast harmonic imaging (CHI). Clin Hemorheol Microcirc 2008; 40: 143-55.
Di Sabation A, Fulle I, Ciccocioppo R, Ricevuti L, Tinozzi FP, Tinozzi S, et al. Doppler enhancement after intravenous Levovist injection in Crohn’s disease. Inflamm Bowel Dis 2002; 8: 251-7.
Serra C, Menzzi G, Labate AM, Giangregorio F, Gionchetti P, Beltrami M, et al. Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn’s disease patients using a low-mechanical index real-time scanning technique with a second-generation ultrasound contrast agent. Eur J Radiol 2007; 62: 114-21.
Quaia E, Migaleddu V, Ba tratella E, Pizzolato R, Rossi A, Grotto M, et al. The diagnostic value of small bowel wall vascularity after sulphurhexafluroridefilled microbubble injection in patients with Crohn’s disease. Correlation with therapeutic effectiveness of specific anti-inflammatory treatment. EurJ Radiol 2009; 69: 438-44.
Giangregorio F, Bertone A, Fanigliulo L, Comparato G, Aragona G, Marinone MG, et al. Predictive value of time-intensity curves obtained with contrastenhanced ultrasonography (CEUS) in the follow-up of 30 patients with Crohn’s disease. J Ultrasound 2009; 12: 151-9.
Kratzer W, Schmidt SA, M ittrach C, Haenle MM, Haenle MM, Mason RA, et al. Contrast-enhanced wideband harmonic imaging ultrasound (SonoVue): A new technique for quantifying bowel wall vascularity in Crohn’s disease. Scand J Gastroenterol 2005; 40: 985-91.
Ripollés T, Martínez MJ, Paredes JM, Blanc E, Flors L, Delgado F. Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy. Radiology 2009; 253: 241-8.
Malagò R, D’Onofrio M, Man tovani W, D’Alpaos G, Foti G, Pezzato A, et al. Contrast-enhanced ultrasonography (CEUS) vs. MRI of the small bowel in the evaluation of Crohn’s disease activity. Radiol Med 2012; 117: 268-81.
Dietrich CF, Averkiou MA, C orreas JM, Lassau N, Leen E, Piscaglia F. An EFSUMB Introduction into Dynamic Contrast-Enhanced Ultrasound (DCEUS) for Quantification of Tumor Perfusion. Ultraschall Med 2012; 33: 344-51.
Girlich C, Schacherer D, Jung EM, Schreyer A, Büttner R. Comparison between a clinical activity index (Harvey-Bradshaw-Index), laboratory inflammation markers and quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound in Crohn’s disease. Eur J Radiol 2012; 81: 1105-9.
Romanini L, Passamonti M, Na varria M, Lanzarotto F, Villanacci V, Grazioli L, et al. Quantitative analysis of contrast-enhanced ultrasonography of the bowel wall can predict disease activity in inflammatory bowel disease. EurJ Radiol 2014; 83: 1317-23.
De Franco A, Di Veronica A, Armuzzi A, Roberto I, Marzo M, De Pascalis B, et al. Ileal Crohn disease: Mural microvascularity quantified with contrastenhanced US correlates with disease activity. Radiology 2012; 262: 680-8.
Białecki M, Białecka A, Lask owska K, Kłopocka M, Liebert A, Lemanowicz A, et al. Contrast-enhanced ultrasonography for the determination of Crohn’s disease activity – preliminary experience. Pol J Radiol 2014; 79: 70-4.
Girlich C, Jung EM, Iesalnieks I, Schreyer AG, Zorger N, Strauch U. Quantitative assessment of bowel wall vascularization in Crohn’s disease with contrast-enhanced ultrasound and perfusion analyses. Clin HemorheolMicrocirc 2009; 43: 141-8.
Quaia E, Cabibbo B, De Paoli L, To scano W, Poillucci G, Assunta Cova M. The value of time-intensity curves obtained after microbubble contrast agent injection to discriminate responder from non-responders to antiinflammatory medication among patients with Crohn’s disease. Eur Radiol 2013; 23: 1650-9.
Peronneau P, Lassau N, Leguerney I, Roche A, Cosgrove D. Contrast ultrasonography: necessity of linear data processing for the quantification of tumor vascularization. Ultraschall Med 2010; 31: 370-8.
Chiorean L, Schreiber-Dietrich D, B raden B, Cui X, Dietrich CF. Transabdominal ultrasound for standardized measurement of bowel wall thickness in normal children and those with Crohn’s disease. Med Ultrason 2014; 16: 319-24.
Thorelius L. Contrast-Enhances Ultr asound in low-energy blunt trauma. In: Lencioni R, editor. Enhancing the role of ultrasound with contrast. Milan: Springer-Verlag Italia; 2006. p. 199.